Neurotransmitter Supplementation Parkinsons

Category: 2

Traditional thinking is that Parkinson’s is a progressive and irreversible disease. We know now that this is not true, but occurs only if the usual drugs are used as treatment (carbidopa/L-dopa combinations, such as Sinemet, etc.). When using these drugs, symptoms eventually return and gradually worsen. Why is this?

The reason is that the drugs currently in use do not address the underlying causes, and the drugs themselves deplete the neurotransmitters, detox (methylation) pathways, and hormones. Parkinson's disease patients do have damage to the dopamine nerves of the brain, but this damage is not the primary cause of deterioration. The primary cause of deterioration is the collapse of the sulfur amino acid-neurotransmitter systems. When this depletion is reversed, the person no longer continues to deteriorate. 

The sulfur amino acid system is the one that forms the basis of methylation and detox. The methylation system is involved in protection of our DNA, and problems here are associated with cancer, autism, lowered immune response, and many others. Detox pathways must be working in order for us to remove or deactivate the toxins that we have been exposed to. The amino acids required for these systems to function normally include methionine, SAMe, cysteine, etc. When these levels are low, symptoms begin because the body is not able to function properly, especially in the area of detox. This in turn affects both the neurotransmitter system and the hormone system. 

Adding any supplement or drug to only one of these areas will result in problems in other two areas. That is, taking only sulfur amino acids will deplete the neurotransmitters and the hormones. Adding only hormones will deplete the sulfur amino acids and the neurotransmitter system, and so on.

Carbidopa, which is used with L-dopa to control nausea, has a host of side effects and problems. Carbidopa does not cross over into the brain barrier. Instead, it inhibits the synthesis of serotonin and catecholamines (dopamine, norepinephrine, and epinephrine) in areas other than the brain, which results in the catastrophic collapse of all of these neurotransmitters. This system collapse due to carbidopa can have life-threatening repercussions, including agranulocytosis (very low white blood cells), hemolytic and non-hemolytic anemia, gastrointestinal bleeding, narcoleptic malignant syndrome, and phlebitis among many others.

Likewise, the use of L-dopa by itself leads to the depletion of neurotransmitters, hormones, and detox (methylation) agents, which then leads to a gradual deterioration of Parkinson’s and an increase in all of its symptoms.

The good news is that we now have a way to successfully restore function to all of these systems without side effects, resulting in the reversal or dramatic improvement of all Parkinson’s symptoms. We are able to achieve this by using specific amino acids that are made by our normal metabolism into the neurotransmitters, stopping the carbidopa, and supplying adequate levels of the sulfur amino acids.

This approach controls nausea, prevents the depletion of all of the systems (neurotransmitters, hormones, and methylation pathways), and returns these systems back to normal function. This is the only approach that can accomplish these results, and the only company that has this approach is NeuroResearch. There are many who say they work with amino acids and neurotransmitters, but none of them have the knowledge to be able to achieve these results.

For more information, visit